Ginger C. Rakestraw

4 Patents

• US124922382025

  Glypican-3-binding Fibronectin Based Scaffold Molecules

  Bristol-myers Squibb Company

  0 cites
• US120775842024

  Methods of Treating Hla-e-expressing Cancers by Administering Antibodies Which Bind Human Natural Killer Cell Inhibitory Receptor Group 2A (NKG2A)

  Bristol-myers Squibb Company

  0 cites
• US119817342024

  Nucleic Acid Molecules Encoding Antibodies Which Bind Natural Killer Cell Inhibitory Receptor Group 2A Protein (NKG2A)

  Bristol-myers Squibb Company

  0 cites
• US118589792024

  Fibronectin Based Scaffold Domain Proteins That Bind PCSK9

  Bristol-meyers Squibb Company

  0 cites